Towson, MD, United States of America

Alexander Sulakvelidze

USPTO Granted Patents = 18 

 

Average Co-Inventor Count = 2.1

ph-index = 7

Forward Citations = 194(Granted Patents)


Location History:

  • Baltimore, MD (US) (2004 - 2008)
  • Brookeville, MD (US) (2014)
  • Towson, IL (US) (2016)
  • Towson, MD (US) (2009 - 2020)

Company Filing History:


Years Active: 2004-2025

Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: Innovations of Alexander Sulakvelidze

Introduction

Alexander Sulakvelidze is a prominent inventor based in Towson, MD (US). He has made significant contributions to the field of bacteriophage research, holding a total of 18 patents. His work focuses on the development and application of bacteriophages for various uses, particularly in food safety and microbiome modulation.

Latest Patents

Among his latest patents, Sulakvelidze has developed isolated bacteriophages that exhibit specificity and lytic activity against specific strains. These inventions include methods for utilizing these bacteriophages, as well as their progeny and derivatives, to control the growth of harmful species in diverse settings. Applications of his work extend to food safety, sanitation, and the modulation of the microbiome, including prebiotics and probiotics.

Career Highlights

Throughout his career, Sulakvelidze has worked with notable companies such as Intralytix, Inc. His innovative research has positioned him as a leader in the field of bacteriophage technology, contributing to advancements that have practical implications in health and safety.

Collaborations

Some of his notable coworkers include Gary R Pasternack and J Glenn Morris. Their collaborative efforts have furthered the understanding and application of bacteriophages in various industries.

Conclusion

Alexander Sulakvelidze's work in bacteriophage research exemplifies the impact of innovation in addressing critical challenges in food safety and health. His contributions continue to influence the field and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…